Inmune Bio INMB
NASDAQ INMB
$1.61 +0.01 (+0.62%)
At close: Oct 21, 2026 · 4:00 PM EDT

Inmune Bio (INMB) Interest Paid (2021 - 2024)

Updated

Analysis

Inmune Bio (INMB) Interest Paid (2021 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 339.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.07 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 1.25 Bn
10 Inmune Bio 42.88 Mn -49.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 1.03 Mn
Sep 30, 2024 138,000.00
Jun 30, 2024 221,000.00
Mar 31, 2024 302,000.00
Dec 31, 2023 384,000.00
Sep 30, 2023 464,000.00
Jun 30, 2023 480,000.00
Mar 31, 2023 450,000.00
Dec 31, 2022 410,000.00
Sep 30, 2022 361,000.00
Jun 30, 2022 310,000.00
Mar 31, 2022 291,000.00
Dec 31, 2021 294,000.00
API Access

Inmune Bio Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=INMB&period=max&api_key=YOUR_API_KEY